During inflammation, functions of microbiota-reactive T cells can be altered: in patients with IBD, microbiota-reactive tissue-resident CD4+ T cells exhibit a Th17-skewed phenotype, possibly reflecting the protective effect of the host to boost tissue integrity [105]. This evidence concerns the gene CD4 and inflammatory bowel disease.